Flexus Biosciences, created in 2013 (United States), from 496 sister brands and 17478 competing brands. The Flexus Biosciences brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. Flexus Biosciences belongs to the Drug Manufacturers business sector.

Flexus Biosciences is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Share price

Date created : 2013 Business sector Drug Manufacturers

Share price and profitability of the share BRISTOL-MYERS SQUIBB COMPANY (Flexus Biosciences)

Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 40.49

Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY (Flexus Biosciences) over 5 years* USD 36.00

Stock market history BRISTOL-MYERS SQUIBB COMPANY (Flexus Biosciences)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
BRISTOL-MYERS SQUIBB COMPANY

FORBIUS
FORBIUS
Kosan Biosciences
Kosan Biosciences
Galecto Biotech
Galecto Biotech
Medarex
Medarex
ZymoGenetics
ZymoGenetics
Amira Pharmaceuticals
Amira Pharmaceuticals
See more brands of BRISTOL-MYERS SQUIBB COMPANY

Rival brands
Flexus Biosciences

Fusion Pharmaceuticals
Fusion Pharmaceuticals
POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS